期刊文献+

367株嗜麦芽窄食单胞菌耐药性分析 被引量:7

Analysis of the Distribution of 367 Strains of Stenotropomonas maltophilia and its Drug Resistance
原文传递
导出
摘要 目的:分析丽水市中心医院嗜麦芽窄食单胞菌的来源、病区分布及耐药情况,为临床合理使用抗菌药提供依据。方法:收集分离自2009年1月-2012年12月的367株嗜麦芽窄食单胞菌,采用法国梅里埃Vitek2-Compact全自动细菌分析仪鉴定细菌,用K-B纸片扩散法进行药敏试验。结果:嗜麦芽窄食单胞菌主要来源于痰液标本,占86.6%,临床分布以ICU最高,占38.4%,对抗菌药米诺环素、左氧氟沙星、复方磺胺甲噁唑、头孢哌酮/舒巴坦的耐药率分别为6.6%,8.8%,10.4%和9.8%。结论:嗜麦芽窄食单胞菌主要分离自ICU、神经外科和呼吸内科的呼吸道标本中,该菌对多数抗菌药有固有耐药,但对米诺环素、左氧氟沙星、复方磺胺甲噁唑和头孢哌酮/舒巴坦的耐药率较低,临床应根据药敏结果合理选用抗菌药。 Objective: To provide basis for clinical rational use of antibacterial by studying the source, distribu tion and drugresistance of Stenotropomonas maltophilia in Lishui Central Hospital. Methods :367 strains of S. maltophilia were collected from January 20009 to December 2012. Identified the bacteria strains with VITEK 2COMPACT instrument. And the drugresistance test adapted KB test. Results: S. maltophilia were mainly isolated from sputum sample, accounting for 86.6%. The clinical distribution of ICU was the highest in the hospital, accounted for 38.4%. The resistance rate of S. maltophilia to minocycline, levofloxacin, trimethoprimsulfamethoxazole and cefoperazone/sulbactam were 6.6%, 8.8%, 10.4% and 9.8%. Conclusion:The S. maltophilia were mainly isolated from specimen of sputum in ICU, neuro surgery department and respiratory medicine department. The organism was inherently resistant to most antibacterial agents, but less resistant to minocyeline, levofloxacin, trimethoprimsulfamethoxazole and cefoperazonesulbactam. The clinician should choose suitable antibiotics based on the results of drug sensitivity tests.
出处 《药物流行病学杂志》 CAS 2014年第11期664-666,共3页 Chinese Journal of Pharmacoepidemiology
关键词 嗜麦芽窄食单胞菌 耐药性 院内感染 抗菌药 Stenotropomonas maltophilia Drug-resistance Nosocomial infection Antibiotics
  • 相关文献

参考文献11

二级参考文献72

  • 1潘计调,陈剑平,郭来洲.嗜麦芽窄食假单孢菌致肺炎伴急性骨髓炎1例[J].中国实用医药,2007,2(14). 被引量:1
  • 2李家泰,朱元珏,胡文芝,吕媛,徐宁,郝邯生,陈亦芳,刘德,孟吴瑾,王哲.舒普深与泰能临床疗效观察[J].中华内科杂志,1996,35(12):819-823. 被引量:19
  • 3汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5):289-295. 被引量:286
  • 4Clinical Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing [S]. M100-S19,2009.
  • 5Clinical Laboratory crobial Dilution and Standard Institute Disk Susceptibility Methods for Antimi Testing of Infrequent ly Isolated or Fastidious Bacteria [S]. Approved Guideline M45-A, 2006, 26(19).
  • 6Yang QW, Wang H, Sun HL, et al. Phenotypic and geno typic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China[J]. Antimicrob Agents Chemother,2010, 54(1): 573-577.
  • 7Wang H, Guo P, Sun HL et al. Molecular epidemiology of clinical isolates of carbapenem resistant Acinetobacter spp from chinese hospitals[J]. Antimicrob Agents Chemother, 2007, 51(11): 4022-4028.
  • 8Perez F, Hujer AM, Hujer KM et al. Global challenge of multidrug resistantAcinetobacterbaumannii[J]. Antimicrob Agents Chemother,2007,51(10) : 3471-3484.
  • 9Boucher HW, Talbot G, Bradley JS, et al. Bad bugs, no drugs: No ESKAPE! An update from the IDSA[J]. Clin Infent Dis, 2009, 48(1):1-12.
  • 10Li J, Nation RL, Milne RW, et al. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria [J]. Intl J Antimicrob Agents, 2005, 25(1).-11 25.

共引文献1622

同被引文献56

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部